Gene delivery targeted to oligodendrocytes using a lentiviral vector

Area of Science:

• Neuroscience
• Molecular Biology
• Gene Therapy

Background:

• Leukodystrophies often stem from mutations affecting oligodendrocyte function.
• Targeted gene delivery to oligodendrocytes is crucial for developing effective leukodystrophy treatments.

Purpose of the Study:

• To develop and evaluate a lentiviral vector for targeted gene delivery to oligodendrocytes.
• To assess the efficiency and duration of gene expression in the central nervous system.

Main Methods:

• A lentiviral vector was engineered with enhanced green fluorescent protein (EGFP) under an oligodendrocyte-specific promoter (2,3-cyclic nucleotide 3-phosphodiesterase).
• The vector was delivered to the neonatal mouse brain via intraventricular and parenchymal injections.

Main Results:

• Widespread EGFP expression was observed in oligodendrocyte lineage cells starting from postnatal day 6.
• Expression persisted for at least 3 months, increasing in intensity and cell number over time.
• Approximately 20.3% of oligodendrocytes showed EGFP expression, with regional variations.

Conclusions:

• Oligodendrocyte-specific lentiviral gene delivery can achieve widespread, long-lasting expression.
• This approach holds potential for gene therapy in leukodystrophies.
• Improving oligodendrocyte transduction rates remains a key challenge.